CD274 and neoplasm: Furthermore, tumor number (HR: 1.756, 95% CI: 0.956–1.327, p = 0.024) and IRE plus PD-1/PD-L1 blockade treatment (HR: 0.459, 95% CI: 0.248–0.824, p = 0.006) were also significant prognostic factors for PFS (Table 4).